查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1486450

全球吸入一氧化氮市场规模研究，依应用（新生儿呼吸治疗、慢性阻塞性肺病、急性呼吸窘迫症候群等）及 2022-2032 年区域预测

Global Inhaled Nitric Oxide Market Size study, by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome, Others), and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

2023年全球吸入一氧化氮市场价值约为11.2亿美元，预计在2024-2032年预测期内将以超过7.70%的健康成长率成长。吸入一氧化氮 (iNO) 是一种医用气体，用作治疗剂，用于改善面临某些呼吸困难的个体的氧合作用。它的作用是扩张肺部血管，促进血液更好地流向有效氧气交换所必需的区域。一氧化氮是体内自然产生的分子，具有舒张血管和调节血压的作用。 。 iNO 针对肺部富氧区域周围的血管，促进放鬆和增加血流量，以促进红血球最佳的氧气摄取。这种针对性的行动对于治疗新生儿呼吸治疗、慢性阻塞性肺病、急性呼吸窘迫症候群等疾病至关重要。因此，iNO 在管理血管和氧合问题方面发挥着至关重要的作用，特别是在新生儿和重症监护情况下。支持 iNO 治疗成人疗效和安全性的强有力的临床证据是支持全球吸入一氧化氮市场成长的关键趋势。

由于婴儿和新生儿肺部疾病治疗方法的增加，加上呼吸系统疾病盛行率的上升和医疗基础设施的进步，吸入一氧化氮市场的成长预计将大幅成长。此外，人们越来越认识到吸入一氧化氮在治疗各种肺部疾病（尤其是新生儿）方面的有效性，这支持了预计 2024 年至 2032 年期间的市场扩张。例如，国家心肺血液研究所2022 年的一篇文章强调了影响新生儿的一系列呼吸问题，包括短暂性呼吸急促、新生儿呼吸窘迫症候群(RDS)、新生儿持续性肺动脉高压(PPHN)、胎粪吸入症候群和支气管肺发育不良（BPD）。 PPHN 是一种以肺血管阻力增高为特征的危重病症，是吸入一氧化氮治疗的主要适应症。其机制涉及选择性扩张肺血管、增强氧合和减少对侵入性通气方法的依赖。此外，美国食品药物管理局批准吸入一氧化氮治疗缺氧性呼吸衰竭，进一步促进了其应用。因此，为了控制新生儿呼吸系统併发症而采用吸入一氧化氮的激增，将推动吸入一氧化氮市场的预期成长。此外，预计针对吸入一氧化氮的深入研究和开发活动将为这种治疗气体的市场带来巨大的成长机会。吸入一氧化氮因其在一系列肺部和心血管疾病方面的治疗潜力而引起了人们极大的兴趣。医学科学和技术的不断进步刺激了吸入一氧化氮的创新应用和配方的研究，促使製药公司和研究机构增加对研发的投资。这些措施旨在改善输送机制、剂量方案并扩大吸入一氧化氮治疗的适应症范围。然而，各个地区严格的应用规范以及该程序产生的高成本预计将阻碍 2022 年至 2032 年的市场成长。

全球吸入一氧化氮市场研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。到 2023 年，北美将成为吸入式一氧化氮市场的主导地区，预计将在整个预测期内以最高的市场份额保持领先地位。先进医疗设施的存在和大量医疗保健支出水平等关键因素促进了吸入一氧化氮等创新治疗方法的采用，这些因素主要推动了区域市场的成长。此外，北美受益于广泛的研究和开发计划，加上有利的监管环境，促进了该地区吸入一氧化氮产品的进步和商业可用性。然而，由于慢性阻塞性肺病（COPD）、肺动脉高压和新生儿缺氧性呼吸衰竭等呼吸系统疾病的盛行率不断上升，预计亚太地区的市场在预测期内将以最快的速度成长。

本报告中包括的主要市场参与者有：

  • 液化空气医疗保健（法国）
  • SOL集团（义大利）
  • Matheson Tri-Gas Inc.（美国）
  • 默克公司（德国）
  • Mallinckrodt 製药公司（英国）
  • Nu-Med Plus Inc.（美国）
  • 博纯有限责任公司（美国）
  • 普莱克斯分销公司（美国）
  • 豪迈集团（英国）
  • 林德集团（德国）

目录

第 1 章：全球吸入一氧化氮市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包容与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 2 章：执行摘要

  • 全球吸入一氧化氮市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 按申请
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 3 章：全球吸入一氧化氮市场动态

  • 市场驱动因素
  • 市场挑战
  • 市场机会

第 4 章：全球吸入一氧化氮市场：产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的 5 力影响分析
  • PESTEL分析
    • 政治的
    • 经济的
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：2022-2032 年全球吸入一氧化氮市场规模及应用预测

  • 新生儿呼吸治疗
  • 慢性阻塞性肺臟疾病
  • 急性呼吸窘迫症候群
  • 其他的

第 6 章：2022-2032 年全球吸入一氧化氮市场规模及按地区预测

  • 北美吸入一氧化氮市场
    • 美国吸入一氧化氮市场
      • 2022-2032 年应用细分规模与预测
    • 加拿大吸入一氧化氮市场
  • 欧洲吸入一氧化氮市场
    • 英国吸入一氧化氮市场
    • 德国吸入一氧化氮市场
    • 法国吸入一氧化氮市场
    • 西班牙吸入一氧化氮市场
    • 义大利吸入一氧化氮市场
    • 欧洲其他地区吸入一氧化氮市场
  • 亚太地区吸入一氧化氮市场
    • 中国吸入一氧化氮市场
    • 印度吸入一氧化氮市场
    • 日本吸入一氧化氮市场
    • 澳洲吸入一氧化氮市场
    • 韩国吸入一氧化氮市场
    • 亚太地区其他地区吸入一氧化氮市场
  • 拉丁美洲吸入一氧化氮市场
    • 巴西吸入一氧化氮市场
    • 墨西哥吸入一氧化氮市场
    • 拉丁美洲其他地区吸入一氧化氮市场
  • 中东和非洲吸入一氧化氮市场
    • 沙乌地阿拉伯吸入一氧化氮市场
    • 南非吸入一氧化氮市场
    • 中东和非洲其他地区吸入一氧化氮市场

第 7 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Air Liquide Healthcare (France)
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • SOL Group (Italy)
    • Matheson Tri-Gas Inc. (United States)
    • Merck KGaA (Germany)
    • Mallinckrodt Pharmaceuticals (United Kingdom)
    • Nu-Med Plus Inc. (United States)
    • Perma Pure LLC (United States)
    • Praxair Distribution Inc. (United States)
    • HALMA PLC (United Kingdom)
    • LINDE PLC (Germany)

第 8 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性

Global Inhaled Nitric Oxide Market is valued approximately at USD 1.12 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.70% over the forecast period 2024-2032. Inhaled nitric oxide (iNO) is a medical gas used as a therapeutic agent to improve oxygenation in individuals facing certain respiratory difficulties. It works by expanding blood vessels in the lungs, promoting better blood flow to areas essential for effective oxygen exchange. Nitric oxide is a naturally produced molecule in the body, playing a role in vasodilation and regulating blood pressure. . iNO targets blood vessels surrounding oxygen-rich areas in the lungs, promoting relaxation and heightened blood flow to facilitate optimal oxygen uptake by red blood cells. This targeted action is essential in treating conditions such as neonatal respiratory treatment, chronic obstructive pulmonary disease, acute respiratory distress syndrome, others. Accordingly, iNO plays a vital role in managing vascular and oxygenation issues, especially in neonatal and critical care scenarios. The robust clinical evidence supporting the efficacy and safety of iNO therapy in adults is a key trend supporting the growth of the Global Inhaled Nitric Oxide Market.

The growth of the inhaled nitric oxide market is anticipated to surge significantly due to increased adoption for managing pulmonary disorders in infants and newborns, coupled with a rise in respiratory disorders prevalence and advancements in healthcare infrastructure. Also, there is growing awareness regarding inhaled nitric oxide's effectiveness in treating various pulmonary conditions, especially in neonates, which is supporting the market expansion during the estimated period of 2024-2032. For instance, a 2022 article from the National Heart, Lung, and Blood Institute highlights the range of breathing problems affecting newborns, including transient tachypnea, neonatal respiratory distress syndrome (RDS), persistent pulmonary hypertension of the newborn (PPHN), meconium aspiration syndrome, and bronchopulmonary dysplasia (BPD). PPHN is a critical condition marked by heightened pulmonary vascular resistance is a primary indication for inhaled nitric oxide therapy. Its mechanism involves selective dilation of pulmonary blood vessels, enhancing oxygenation, and reducing reliance on invasive ventilation methods. Furthermore, the U.S. Food and Drug Administration's approval for inhaled nitric oxide in treating hypoxic respiratory failure further bolsters its adoption. Consequently, the surge in adoption of inhaled nitric oxide in order to manage respiratory complications in newborns is poised to drive the projected growth of the inhaled nitric oxide market. Furthermore, intensive research and development activities focused on inhaled nitric oxide are anticipated to present substantial growth opportunities within the market for this therapeutic gas. Inhaled nitric oxide has attracted considerable interest due to its promising therapeutic potential across a spectrum of pulmonary and cardiovascular conditions. The ongoing progress in medical science and technology has spurred investigations into innovative applications and formulations of inhaled nitric oxide, prompting heightened investments in research and development by pharmaceutical firms and research establishments. These initiatives aim to refine delivery mechanisms, dosage protocols, and broaden the scope of indications for inhaled nitric oxide therapy. However, stringent application norms across various regions, along with high costs incurred with the procedure is expected to hinder the market growth between 2022 and 2032.

The key regions considered for the global Inhaled Nitric Oxide Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is a dominating region in the inhaled nitric oxide market and is projected to sustain its leading position with the highest number of market shares throughout the forecast period. Key factors such as presence of advanced healthcare facilities and substantial healthcare expenditure levels that facilitate the adoption of innovative treatments like inhaled nitric oxide are primarily bolstering the regional market growth. Moreover, North America benefits from extensive research and development initiatives, coupled with a favorable regulatory landscape, which have fostered the advancement and commercial availability of inhaled nitric oxide products in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to the rising prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and neonatal hypoxic respiratory failure.

Major market player included in this report are:

  • Air Liquide Healthcare (France)
  • SOL Group (Italy)
  • Matheson Tri-Gas Inc. (United States)
  • Merck KGaA (Germany)
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Nu-Med Plus Inc. (United States)
  • Perma Pure LLC (United States)
  • Praxair Distribution Inc. (United States)
  • HALMA PLC (United Kingdom)
  • LINDE PLC (Germany)

The detailed segments and sub-segment of the market are explained below:

By Application

  • Neonatal Respiratory Treatment
  • Chronic Obstructive Pulmonary Disease
  • Acute Respiratory Distress Syndrome
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Inhaled Nitric Oxide Market Definition and Research Assumptions

  • 1.1.Research Objective
  • 1.2.Market Definition
  • 1.3.Research Assumptions
    • 1.3.1.Inclusion & Exclusion
    • 1.3.2.Limitations
    • 1.3.3.Supply Side Analysis
      • 1.3.3.1.Availability
      • 1.3.3.2.Infrastructure
      • 1.3.3.3.Regulatory Environment
      • 1.3.3.4.Market Competition
      • 1.3.3.5.Economic Viability (Consumer's Perspective)
    • 1.3.4.Demand Side Analysis
      • 1.3.4.1.Regulatory frameworks
      • 1.3.4.2.Technological Advancements
      • 1.3.4.3.Environmental Considerations
      • 1.3.4.4.Consumer Awareness & Acceptance
  • 1.4.Estimation Methodology
  • 1.5.Years Considered for the Study
  • 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

  • 2.1.Global Inhaled Nitric Oxide Market Size & Forecast (2022- 2032)
  • 2.2.Regional Summary
  • 2.3.Segmental Summary
    • 2.3.1.By Application
  • 2.4.Key Trends
  • 2.5.Recession Impact
  • 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Inhaled Nitric Oxide Market Dynamics

  • 3.1.Market Drivers
  • 3.2.Market Challenges
  • 3.3.Market Opportunities

Chapter 4.Global Inhaled Nitric Oxide Market: Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
    • 4.1.7.Porter's 5 Force Impact Analysis
  • 4.2.PESTEL Analysis
    • 4.2.1.Political
    • 4.2.2.Economic
    • 4.2.3.Social
    • 4.2.4.Technological
    • 4.2.5.Environmental
    • 4.2.6.Legal
  • 4.3.Top investment opportunity
  • 4.4.Top winning strategies
  • 4.5.Disruptive Trends
  • 4.6.Industry Expert Perspective
  • 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Inhaled Nitric Oxide Market Size & Forecasts by Application 2022-2032

  • 5.1.Neonatal Respiratory Treatment
  • 5.2.Chronic Obstructive Pulmonary Disease
  • 5.3.Acute Respiratory Distress Syndrome
  • 5.4.Others

Chapter 6.Global Inhaled Nitric Oxide Market Size & Forecasts by Region 2022-2032

  • 6.1.North America Inhaled Nitric Oxide Market
    • 6.1.1.U.S. Inhaled Nitric Oxide Market
      • 6.1.1.1. Application breakdown size & forecasts, 2022-2032
    • 6.1.2.Canada Inhaled Nitric Oxide Market
  • 6.2.Europe Inhaled Nitric Oxide Market
    • 6.2.1.U.K. Inhaled Nitric Oxide Market
    • 6.2.2.Germany Inhaled Nitric Oxide Market
    • 6.2.3.France Inhaled Nitric Oxide Market
    • 6.2.4.Spain Inhaled Nitric Oxide Market
    • 6.2.5.Italy Inhaled Nitric Oxide Market
    • 6.2.6.Rest of Europe Inhaled Nitric Oxide Market
  • 6.3.Asia-Pacific Inhaled Nitric Oxide Market
    • 6.3.1.China Inhaled Nitric Oxide Market
    • 6.3.2.India Inhaled Nitric Oxide Market
    • 6.3.3.Japan Inhaled Nitric Oxide Market
    • 6.3.4.Australia Inhaled Nitric Oxide Market
    • 6.3.5.South Korea Inhaled Nitric Oxide Market
    • 6.3.6.Rest of Asia Pacific Inhaled Nitric Oxide Market
  • 6.4.Latin America Inhaled Nitric Oxide Market
    • 6.4.1.Brazil Inhaled Nitric Oxide Market
    • 6.4.2.Mexico Inhaled Nitric Oxide Market
    • 6.4.3.Rest of Latin America Inhaled Nitric Oxide Market
  • 6.5.Middle East & Africa Inhaled Nitric Oxide Market
    • 6.5.1. Saudi Arabia Inhaled Nitric Oxide Market
    • 6.5.2. South Africa Inhaled Nitric Oxide Market
    • 6.5.3.Rest of Middle East & Africa Inhaled Nitric Oxide Market

Chapter 7.Competitive Intelligence

  • 7.1.Key Company SWOT Analysis
  • 7.2.Top Market Strategies
  • 7.3.Company Profiles
    • 7.3.1.Air Liquide Healthcare (France)
      • 7.3.1.1.Key Information
      • 7.3.1.2.Overview
      • 7.3.1.3.Financial (Subject to Data Availability)
      • 7.3.1.4.Product Summary
      • 7.3.1.5.Market Strategies
    • 7.3.2.SOL Group (Italy)
    • 7.3.3.Matheson Tri-Gas Inc. (United States)
    • 7.3.4.Merck KGaA (Germany)
    • 7.3.5.Mallinckrodt Pharmaceuticals (United Kingdom)
    • 7.3.6.Nu-Med Plus Inc. (United States)
    • 7.3.7.Perma Pure LLC (United States)
    • 7.3.8.Praxair Distribution Inc. (United States)
    • 7.3.9.HALMA PLC (United Kingdom)
    • 7.3.10.LINDE PLC (Germany)

Chapter 8.Research Process

  • 8.1.Research Process
    • 8.1.1.Data Mining
    • 8.1.2.Analysis
    • 8.1.3.Market Estimation
    • 8.1.4.Validation
    • 8.1.5.Publishing
  • 8.2.Research Attributes

LIST OF TABLES

  • TABLE 1.Global Inhaled Nitric Oxide Market, report scope
  • TABLE 2.Global Inhaled Nitric Oxide Market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3.Global Inhaled Nitric Oxide Market estimates & forecasts by Application 2022-2032 (USD Billion)
  • TABLE 4.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 5.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14.U.S. Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 16.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17.Canada Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 18.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 19.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20.UK Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 21.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 22.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23.Germany Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 24.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 25.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26.France Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 27.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 28.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29.Italy Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 30.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 31.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32.Spain Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 33.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 34.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35.RoE Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 36.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 37.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38.China Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 39.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 40.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41.India Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 42.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 43.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44.Japan Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 45.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 46.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47.Australia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 48.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 49.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50.South Korea Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 51.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 52.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53.
  • TABLE 54.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 55.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 56.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57.Brazil Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 58.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 59.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60.Mexico Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 61.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 62.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63.RoLA Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 64.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 65.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 67.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 70.
  • TABLE 71.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 72.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76.List of secondary sources, used in the study of Global Inhaled Nitric Oxide Market.
  • TABLE 77.List of primary sources, used in the study of Global Inhaled Nitric Oxide Market.
  • TABLE 78.Years considered for the study.
  • TABLE 79.Exchange rates considered.

LIST OF FIGURES

  • FIG 1.Global Inhaled Nitric Oxide Market, research methodology
  • FIG 2.Global Inhaled Nitric Oxide Market, market estimation techniques
  • FIG 3.Global market size estimates & forecast methods.
  • FIG 4.Global Inhaled Nitric Oxide Market, key trends 2023
  • FIG 5.Global Inhaled Nitric Oxide Market, growth prospects 2022-2032
  • FIG 6.Global Inhaled Nitric Oxide Market, porters 5 force model
  • FIG 7.Global Inhaled Nitric Oxide Market, pestel analysis
  • FIG 8.Global Inhaled Nitric Oxide Market, value chain analysis
  • FIG 9.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
  • FIG 10.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
  • FIG 11.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
  • FIG 12.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
  • FIG 13.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
  • FIG 14.Global Inhaled Nitric Oxide Market, regional snapshot 2022 & 2032
  • FIG 15.North America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
  • FIG 16.Europe Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
  • FIG 17.Asia pacific Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
  • FIG 18.Latin America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
  • FIG 19.Middle East & Africa Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
  • FIG 20.Global Inhaled Nitric Oxide Market, company market share analysis (2023)